This report aims to provide a comprehensive presentation of the global market for Biologic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic Drugs. This report contains market size and forecasts of Biologic Drugs in global, including the following market information:
Global Biologic Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Biologic Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Biologic Drugs companies in 2022 (%)
The global Biologic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Humira Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biologic Drugs include Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., Pfizer, Amgen, Sanofi, Novartis and Eli Lilly, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biologic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologic Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biologic Drugs Market Segment Percentages, by Type, 2022 (%)
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
Global Biologic Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biologic Drugs Market Segment Percentages, by Application, 2022 (%)
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
Global Biologic Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biologic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biologic Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Biologic Drugs revenues share in global market, 2022 (%)
Key companies Biologic Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Biologic Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biologic Drugs, market overview.
Chapter 2: Global Biologic Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Biologic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biologic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biologic Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biologic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologic Drugs Overall Market Size
2.1 Global Biologic Drugs Market Size: 2022 VS 2032
2.2 Global Biologic Drugs Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Biologic Drugs Sales: 2018-2032
3 Company Landscape
3.1 Top Biologic Drugs Players in Global Market
3.2 Top Global Biologic Drugs Companies Ranked by Revenue
3.3 Global Biologic Drugs Revenue by Companies
3.4 Global Biologic Drugs Sales by Companies
3.5 Global Biologic Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biologic Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biologic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biologic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Biologic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Biologic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biologic Drugs Market Size Markets, 2022 & 2032
4.1.2 Humira
4.1.3 Remicade
4.1.4 Rituxan
4.1.5 Enbrel
4.1.6 Lantus
4.1.7 Avastin
4.1.8 Herceptin
4.1.9 Others
4.2 By Type - Global Biologic Drugs Revenue & Forecasts
4.2.1 By Type - Global Biologic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Biologic Drugs Revenue, 2024-2032
4.2.3 By Type - Global Biologic Drugs Revenue Market Share, 2018-2032
4.3 By Type - Global Biologic Drugs Sales & Forecasts
4.3.1 By Type - Global Biologic Drugs Sales, 2018-2023
4.3.2 By Type - Global Biologic Drugs Sales, 2024-2032
4.3.3 By Type - Global Biologic Drugs Sales Market Share, 2018-2032
4.4 By Type - Global Biologic Drugs Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biologic Drugs Market Size, 2022 & 2032
5.1.2 Diabetes
5.1.3 Inflammation
5.1.4 Auto-Immune Diseases
5.1.5 Blood Diseases
5.1.6 Cardiovascular Diseases
5.1.7 Others
5.2 By Application - Global Biologic Drugs Revenue & Forecasts
5.2.1 By Application - Global Biologic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Biologic Drugs Revenue, 2024-2032
5.2.3 By Application - Global Biologic Drugs Revenue Market Share, 2018-2032
5.3 By Application - Global Biologic Drugs Sales & Forecasts
5.3.1 By Application - Global Biologic Drugs Sales, 2018-2023
5.3.2 By Application - Global Biologic Drugs Sales, 2024-2032
5.3.3 By Application - Global Biologic Drugs Sales Market Share, 2018-2032
5.4 By Application - Global Biologic Drugs Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Biologic Drugs Market Size, 2022 & 2032
6.2 By Region - Global Biologic Drugs Revenue & Forecasts
6.2.1 By Region - Global Biologic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Biologic Drugs Revenue, 2024-2032
6.2.3 By Region - Global Biologic Drugs Revenue Market Share, 2018-2032
6.3 By Region - Global Biologic Drugs Sales & Forecasts
6.3.1 By Region - Global Biologic Drugs Sales, 2018-2023
6.3.2 By Region - Global Biologic Drugs Sales, 2024-2032
6.3.3 By Region - Global Biologic Drugs Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Biologic Drugs Revenue, 2018-2032
6.4.2 By Country - North America Biologic Drugs Sales, 2018-2032
6.4.3 US Biologic Drugs Market Size, 2018-2032
6.4.4 Canada Biologic Drugs Market Size, 2018-2032
6.4.5 Mexico Biologic Drugs Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Biologic Drugs Revenue, 2018-2032
6.5.2 By Country - Europe Biologic Drugs Sales, 2018-2032
6.5.3 Germany Biologic Drugs Market Size, 2018-2032
6.5.4 France Biologic Drugs Market Size, 2018-2032
6.5.5 U.K. Biologic Drugs Market Size, 2018-2032
6.5.6 Italy Biologic Drugs Market Size, 2018-2032
6.5.7 Russia Biologic Drugs Market Size, 2018-2032
6.5.8 Nordic Countries Biologic Drugs Market Size, 2018-2032
6.5.9 Benelux Biologic Drugs Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Biologic Drugs Revenue, 2018-2032
6.6.2 By Region - Asia Biologic Drugs Sales, 2018-2032
6.6.3 China Biologic Drugs Market Size, 2018-2032
6.6.4 Japan Biologic Drugs Market Size, 2018-2032
6.6.5 South Korea Biologic Drugs Market Size, 2018-2032
6.6.6 Southeast Asia Biologic Drugs Market Size, 2018-2032
6.6.7 India Biologic Drugs Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Biologic Drugs Revenue, 2018-2032
6.7.2 By Country - South America Biologic Drugs Sales, 2018-2032
6.7.3 Brazil Biologic Drugs Market Size, 2018-2032
6.7.4 Argentina Biologic Drugs Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biologic Drugs Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Biologic Drugs Sales, 2018-2032
6.8.3 Turkey Biologic Drugs Market Size, 2018-2032
6.8.4 Israel Biologic Drugs Market Size, 2018-2032
6.8.5 Saudi Arabia Biologic Drugs Market Size, 2018-2032
6.8.6 UAE Biologic Drugs Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Biologic Drugs Major Product Offerings
7.1.4 Roche Biologic Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Biologic Drugs Major Product Offerings
7.2.4 Abbott Laboratories Biologic Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Biologic Drugs Major Product Offerings
7.3.4 Johnson & Johnson Biologic Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Merck & Co.
7.4.1 Merck & Co. Company Summary
7.4.2 Merck & Co. Business Overview
7.4.3 Merck & Co. Biologic Drugs Major Product Offerings
7.4.4 Merck & Co. Biologic Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Merck & Co. Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Biologic Drugs Major Product Offerings
7.5.4 Pfizer Biologic Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Biologic Drugs Major Product Offerings
7.6.4 Amgen Biologic Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Biologic Drugs Major Product Offerings
7.7.4 Sanofi Biologic Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Biologic Drugs Major Product Offerings
7.8.4 Novartis Biologic Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Eli Lilly
7.9.1 Eli Lilly Company Summary
7.9.2 Eli Lilly Business Overview
7.9.3 Eli Lilly Biologic Drugs Major Product Offerings
7.9.4 Eli Lilly Biologic Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Eli Lilly Key News & Latest Developments
7.10 Amgen
7.10.1 Amgen Company Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Biologic Drugs Major Product Offerings
7.10.4 Amgen Biologic Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Amgen Key News & Latest Developments
8 Global Biologic Drugs Production Capacity, Analysis
8.1 Global Biologic Drugs Production Capacity, 2018-2032
8.2 Biologic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Biologic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biologic Drugs Supply Chain Analysis
10.1 Biologic Drugs Industry Value Chain
10.2 Biologic Drugs Upstream Market
10.3 Biologic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biologic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Biologic Drugs in Global Market
Table 2. Top Biologic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Biologic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Biologic Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Biologic Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Biologic Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Biologic Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Biologic Drugs Product Type
Table 9. List of Global Tier 1 Biologic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biologic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Biologic Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Biologic Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Biologic Drugs Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Biologic Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Biologic Drugs Sales (K Units), 2024-2032
Table 16. By Application ? Global Biologic Drugs Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Biologic Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Biologic Drugs Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Biologic Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Biologic Drugs Sales (K Units), 2024-2032
Table 21. By Region ? Global Biologic Drugs Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Biologic Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Biologic Drugs Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Biologic Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Biologic Drugs Sales (K Units), 2024-2032
Table 26. By Country - North America Biologic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Biologic Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Biologic Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Biologic Drugs Sales, (K Units), 2024-2032
Table 30. By Country - Europe Biologic Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Biologic Drugs Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Biologic Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Biologic Drugs Sales, (K Units), 2024-2032
Table 34. By Region - Asia Biologic Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Biologic Drugs Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Biologic Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Biologic Drugs Sales, (K Units), 2024-2032
Table 38. By Country - South America Biologic Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Biologic Drugs Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Biologic Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Biologic Drugs Sales, (K Units), 2024-2032
Table 42. By Country - Middle East & Africa Biologic Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Biologic Drugs Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Biologic Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Biologic Drugs Sales, (K Units), 2024-2032
Table 46. Roche Company Summary
Table 47. Roche Biologic Drugs Product Offerings
Table 48. Roche Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Abbott Laboratories Company Summary
Table 51. Abbott Laboratories Biologic Drugs Product Offerings
Table 52. Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Abbott Laboratories Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Biologic Drugs Product Offerings
Table 56. Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. Merck & Co. Company Summary
Table 59. Merck & Co. Biologic Drugs Product Offerings
Table 60. Merck & Co. Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Merck & Co. Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Biologic Drugs Product Offerings
Table 64. Pfizer Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. Amgen Company Summary
Table 67. Amgen Biologic Drugs Product Offerings
Table 68. Amgen Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Amgen Key News & Latest Developments
Table 70. Sanofi Company Summary
Table 71. Sanofi Biologic Drugs Product Offerings
Table 72. Sanofi Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Sanofi Key News & Latest Developments
Table 74. Novartis Company Summary
Table 75. Novartis Biologic Drugs Product Offerings
Table 76. Novartis Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Novartis Key News & Latest Developments
Table 78. Eli Lilly Company Summary
Table 79. Eli Lilly Biologic Drugs Product Offerings
Table 80. Eli Lilly Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Eli Lilly Key News & Latest Developments
Table 82. Amgen Company Summary
Table 83. Amgen Biologic Drugs Product Offerings
Table 84. Amgen Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Amgen Key News & Latest Developments
Table 86. Biologic Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Biologic Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Biologic Drugs Production by Region, 2018-2023 (K Units)
Table 89. Global Biologic Drugs Production by Region, 2024-2032 (K Units)
Table 90. Biologic Drugs Market Opportunities & Trends in Global Market
Table 91. Biologic Drugs Market Drivers in Global Market
Table 92. Biologic Drugs Market Restraints in Global Market
Table 93. Biologic Drugs Raw Materials
Table 94. Biologic Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Biologic Drugs Downstream
Table 96. Biologic Drugs Downstream Clients in Global Market
Table 97. Biologic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biologic Drugs Segment by Type in 2022
Figure 2. Biologic Drugs Segment by Application in 2022
Figure 3. Global Biologic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biologic Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Biologic Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. Biologic Drugs Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biologic Drugs Revenue in 2022
Figure 9. By Type - Global Biologic Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Biologic Drugs Revenue Market Share, 2018-2032
Figure 11. By Type - Global Biologic Drugs Sales Market Share, 2018-2032
Figure 12. By Type - Global Biologic Drugs Price (USD/Unit), 2018-2032
Figure 13. By Application - Global Biologic Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Biologic Drugs Revenue Market Share, 2018-2032
Figure 15. By Application - Global Biologic Drugs Sales Market Share, 2018-2032
Figure 16. By Application - Global Biologic Drugs Price (USD/Unit), 2018-2032
Figure 17. By Region - Global Biologic Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Biologic Drugs Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Biologic Drugs Revenue Market Share, 2018-2032
Figure 20. By Region - Global Biologic Drugs Sales Market Share, 2018-2032
Figure 21. By Country - North America Biologic Drugs Revenue Market Share, 2018-2032
Figure 22. By Country - North America Biologic Drugs Sales Market Share, 2018-2032
Figure 23. US Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Biologic Drugs Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Biologic Drugs Sales Market Share, 2018-2032
Figure 28. Germany Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. France Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Biologic Drugs Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Biologic Drugs Sales Market Share, 2018-2032
Figure 37. China Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. India Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Biologic Drugs Revenue Market Share, 2018-2032
Figure 43. By Country - South America Biologic Drugs Sales Market Share, 2018-2032
Figure 44. Brazil Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Biologic Drugs Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Biologic Drugs Sales Market Share, 2018-2032
Figure 48. Turkey Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Biologic Drugs Revenue, (US$, Mn), 2018-2032
Figure 52. Global Biologic Drugs Production Capacity (K Units), 2018-2032
Figure 53. The Percentage of Production Biologic Drugs by Region, 2022 VS 2032
Figure 54. Biologic Drugs Industry Value Chain
Figure 55. Marketing Channels
